Highly informative marker sets consisting of genes with low individual degree of differential expression
Open Access
- 8 October 2015
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 14967
Abstract
Genes with significant differential expression are traditionally used to reveal the genetic background underlying phenotypic differences between cancer cells. We hypothesized that informative marker sets can be obtained by combining genes with a relatively low degree of individual differential expression. We developed a method for construction of highly informative gene combinations aimed at the maximization of the cumulative informative power and identified sets of 2–5 genes efficiently predicting recurrence for ER-positive breast cancer patients. The gene combinations constructed on the basis of microarray data were successfully applied to data acquired by RNA-seq. The developed method provides the basis for the generation of highly efficient prognostic and predictive gene signatures for cancer and other diseases. The identified gene sets can potentially reveal novel essential segments of gene interaction networks and pathways implied in cancer progression.Keywords
This publication has 33 references indexed in Scilit:
- Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young WomenPLOS ONE, 2013
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast CancerPLOS ONE, 2013
- Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancerBreast Cancer Research and Treatment, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Identification of high-quality cancer prognostic markers and metastasis network modulesNature Communications, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Mapping and quantifying mammalian transcriptomes by RNA-SeqNature Methods, 2008
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProceedings of the National Academy of Sciences, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002